Safety assessment study on excessive intake of test supplement -A randomized, double blind, placebo controlled, parallel study- - Safety assessment study on excessive intake of test supplement

FANCL Corporation0 个研究点目标入组 100 人开始时间: 2018年7月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Subjects who have judged to have problems with participation in examination due to clinical laboratory test values or cardiorespiratory abnormality 2.Subjects who are at risk of developing allergy in relation to the test supplement. 3.Subjects who have a disease requiring regular medication. Subjects who have a history of serious illness requiring medication treatment 4.Subjects whose clinical laboratory values and measured values before ingestion are significantly out of the reference range 5.Subjects who are participating in other clinical trials when start of the examination period 6.Subjects who intend to become pregnant or lactating 7.Subjects who are judged as unsuitable for the study by background survey results 8.Subjects who are judged as unsuitable for the study by the principal doctor

发起方